VIDEO: Two-year data show good visual, anatomic outcomes for Susvimo in wet AMD

ByCharles C. Wykoff, MD, PhD

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Acute Kidney Injury.

Subscribe

Added to email alerts

You've successfully added Acute Kidney Injury to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Acute Kidney Injury to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

In this Healio Video Perspective, Charles C. Wykoff, MD, PhD, discusses 2-year results from the Archway study of Susvimo (ranibizumab injection, Genentech) to treat wet AMD, presented at Angiogenesis, Exudation, and Degeneration 2022.

Published by:

Sources/Disclosures

Collapse

Source: Charles C. Wykoff, MD, PhD

Read more from Angiogenesis, Exudation and Degeneration Meeting

View all

March 03, 2025

1 min read

Save

Older patients with DME have weaker response to anti-VEGF treatment

February 26, 2025

2 min read

Save

GA lesion location plays role in vision-related quality of life

February 21, 2024

1 min read

Save

En face OCT identifies cRORA as hypertransmission defects

February 15, 2024

1 min read

Save

Precursor lesions may help identify risk for atrophy in AMD

February 15, 2024

1 min read

Save

Precursor lesions may help identify risk for atrophy in AMD

February 13, 2024

1 min read

Save

Study provides multimodal assessment of geographic atrophy precursors

February 13, 2024

1 min read

Save

Study provides multimodal assessment of geographic atrophy precursors

February 13, 2024

4 min watch

Save

VIDEO: Faricimab demonstrates positive real-world results at 1 year in neovascular AMD

February 09, 2024

4 min watch

Save

VIDEO: 4D-150 shows positive interim results in phase 2 trial for severe wet AMD

Previous

Next

Read more about

wet age-related macular degeneration

ranibizumab

Add topic to email alerts

Please provide your email address to receive an email when new articles are posted on Acute Kidney Injury.

Subscribe

Added to email alerts

You've successfully added Acute Kidney Injury to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

You've successfully added Acute Kidney Injury to your alerts. You will receive an email when new content is published.

Click Here to Manage Email Alerts

Back to Healio

We were unable to process your request. Please try again later. If you continue to have this issue please contact customerservice@slackinc.com.

Back to Healio

• Facebook
• Twitter
• LinkedIn
• Email
• Print
• Comment